Viral Vaccines
1 / 1
Failed to load
License Agreement
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China
Nuance Pharma
PR-M03-22-08Mar 21, 2022
Failed to load
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01Mar 01, 2022
Failed to load
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18Feb 18, 2022
Failed to load
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17Nov 08, 2021
Failed to load
Vaccine Development
The Advantages of Implementing Plant-Based Vaccines
Sylvain Marcel, Ph.D; Robert Erwin; Brian R. Berquist, Ph.D.
iBio, Inc.
PAP-Q3-20-CL-021Sep 29, 2020
Failed to load
Moderna Highlights Opportunity of mRNA Vaccines
Moderna
PR-M04-20-NI-019Apr 14, 2020
Failed to load
AAV and LV Vectors
Supporting AAV and Lentiviral Vector Development and Commercialization
James Brown, Ph.D.
Aldevron
PAP-Q2-2019-CL-005May 24, 2019
Failed to load
Vaccine
Tactiva Therapeutics Announces License to Oncolytic Vaccinia Virus Armed With CXCR4 Antagonist for Treatment of Ovarian Cancer
Tactiva Therapeutics
PR-M11-18-NI-109Nov 30, 2018
Failed to load
Expansion
Fujifilm Announces The Expansion Of Its Fill Finish Services
Fujifilm Biotechnologies
PR-M05-18-NI-095May 25, 2018
1 / 1